Advertisement
New Zealand markets closed
  • NZX 50

    11,946.43
    +143.15 (+1.21%)
     
  • NZD/USD

    0.5944
    +0.0007 (+0.12%)
     
  • NZD/EUR

    0.5549
    +0.0004 (+0.06%)
     
  • ALL ORDS

    7,937.50
    -0.40 (-0.01%)
     
  • ASX 200

    7,683.00
    -0.50 (-0.01%)
     
  • OIL

    82.72
    -0.09 (-0.11%)
     
  • GOLD

    2,331.50
    -6.90 (-0.30%)
     
  • NASDAQ

    17,526.80
    +55.33 (+0.32%)
     
  • FTSE

    8,040.38
    -4.43 (-0.06%)
     
  • Dow Jones

    38,460.92
    -42.77 (-0.11%)
     
  • DAX

    18,088.70
    -48.95 (-0.27%)
     
  • Hang Seng

    17,283.42
    +82.15 (+0.48%)
     
  • NIKKEI 225

    37,776.59
    -683.49 (-1.78%)
     
  • NZD/JPY

    92.3400
    +0.2250 (+0.24%)
     

2 Best Medical Device Stocks for 2023

2 Best Medical Device Stocks for 2023

Over the past five years, for instance, industry giants like Medtronic have lagged the broader markets from a capital appreciation standpoint due to headwinds emanating from legacy portfolios, while up-and-coming device makers such as the diabetes care company DexCom have yielded life-changing gains for shareholders. Armed with this background, I think the diabetes care specialist Insulet (NASDAQ: PODD) and the surgical device company Conmed (NYSE: CNMD) are poised to be medtech's two best performers in 2023. The diabetes care specialist Insulet has been a rare bright spot in the medtech stock space in 2022.